These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

183 related articles for article (PubMed ID: 32733352)

  • 21. Evolution of prodromal clinical markers of Parkinson disease in a GBA mutation-positive cohort.
    Beavan M; McNeill A; Proukakis C; Hughes DA; Mehta A; Schapira AH
    JAMA Neurol; 2015 Feb; 72(2):201-8. PubMed ID: 25506732
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Depression and Related Factors in Patients with Parkinson's Disease at High Altitude.
    Cao Y; Li G; Xue J; Zhang G; Gao S; Huang Y; Zhu A
    Neuropsychiatr Dis Treat; 2021; 17():1353-1362. PubMed ID: 33986595
    [TBL] [Abstract][Full Text] [Related]  

  • 23. Comparison of Mini-Mental State Examination and Montreal Cognitive Assessment Ratings Across Levels of Parkinson's Disease Severity.
    Snyder A; Gruber-Baldini AL; Rainer von Coelln F; Savitt JM; Reich SG; Armstrong MJ; Shulman LM
    J Parkinsons Dis; 2021; 11(4):1995-2003. PubMed ID: 34366371
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Exploring the Effects of Genetic Variants on Clinical Profiles of Parkinson's Disease Assessed by the Unified Parkinson's Disease Rating Scale and the Hoehn-Yahr Stage.
    Shi C; Zheng Z; Wang Q; Wang C; Zhang D; Zhang M; Chan P; Wang X
    PLoS One; 2016; 11(6):e0155758. PubMed ID: 27299523
    [TBL] [Abstract][Full Text] [Related]  

  • 25. The glucocerebrosidase mutations and uric acid levels in Parkinson's disease: A 3-years investigation of a potential biomarker".
    Mozafar M; Kazemian S; Hoseini E; Mohammadi M; Alimoghadam R; Shafie M; Mayeli M;
    Clin Park Relat Disord; 2023; 8():100177. PubMed ID: 36590455
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Cost-effectiveness analysis of the Parkinson's KinetiGraph and clinical assessment in the management of Parkinson's disease.
    Chaudhuri KR; Hand A; Obam F; Belsey J
    J Med Econ; 2022; 25(1):774-782. PubMed ID: 35593687
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Large-scale identification of clinical and genetic predictors of motor progression in patients with newly diagnosed Parkinson's disease: a longitudinal cohort study and validation.
    Latourelle JC; Beste MT; Hadzi TC; Miller RE; Oppenheim JN; Valko MP; Wuest DM; Church BW; Khalil IG; Hayete B; Venuto CS
    Lancet Neurol; 2017 Nov; 16(11):908-916. PubMed ID: 28958801
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Diffusion tensor imaging techniques show that parkin gene S/N167 polymorphism is responsible for extensive brain white matter damage in patients with Parkinson's disease.
    Yu J; Shi J; Chen L; Wang Y; Cai G; Chen X; Hong W; Ye Q
    Heliyon; 2023 Aug; 9(8):e18395. PubMed ID: 37600423
    [TBL] [Abstract][Full Text] [Related]  

  • 29. How to identify tremor dominant and postural instability/gait difficulty groups with the movement disorder society unified Parkinson's disease rating scale: comparison with the unified Parkinson's disease rating scale.
    Stebbins GT; Goetz CG; Burn DJ; Jankovic J; Khoo TK; Tilley BC
    Mov Disord; 2013 May; 28(5):668-70. PubMed ID: 23408503
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and dopamine transporter imaging characteristics of non-manifest LRRK2 and GBA mutation carriers in the Parkinson's Progression Markers Initiative (PPMI): a cross-sectional study.
    Simuni T; Uribe L; Cho HR; Caspell-Garcia C; Coffey CS; Siderowf A; Trojanowski JQ; Shaw LM; Seibyl J; Singleton A; Toga AW; Galasko D; Foroud T; Tosun D; Poston K; Weintraub D; Mollenhauer B; Tanner CM; Kieburtz K; Chahine LM; Reimer A; Hutten SJ; Bressman S; Marek K;
    Lancet Neurol; 2020 Jan; 19(1):71-80. PubMed ID: 31678032
    [TBL] [Abstract][Full Text] [Related]  

  • 31. LRRK2-associated Parkinson's disease patients have better stereopsis than idiopathic Parkinson disease.
    Sun L; Chan P
    Clin Neurol Neurosurg; 2018 Jun; 169():174-177. PubMed ID: 29705653
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Tremor and clinical fluctuation are related to sleep disorders in Chinese patients with Parkinson's disease.
    Zhou H; Shen C; Chen J; Qian H; Zheng Y; Liu Y; Xian W; Pei Z; Chen L
    Transl Neurodegener; 2014; 3():21. PubMed ID: 25349692
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Circulatory 25(OH)D and 1,25(OH)
    Ogura H; Hatip-Al-Khatib I; Suenaga M; Hatip FB; Mishima T; Fujioka S; Ouma S; Matsunaga Y; Tsuboi Y
    eNeurologicalSci; 2021 Dec; 25():100369. PubMed ID: 34611554
    [TBL] [Abstract][Full Text] [Related]  

  • 34. The semicircular canal function is preserved with little impact on falls in patients with mild Parkinson's disease.
    Hong JP; Kwon H; Park E; Lee SU; Lee CN; Kim BJ; Kim JS; Park KW
    Parkinsonism Relat Disord; 2024 Jan; 118():105933. PubMed ID: 38007917
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Dream Content Predicts Motor and Cognitive Decline in Parkinson's Disease.
    Otaiku AI
    Mov Disord Clin Pract; 2021 Oct; 8(7):1041-1051. PubMed ID: 34631940
    [TBL] [Abstract][Full Text] [Related]  

  • 36. The neutrophil-to-lymphocyte ratio, lymphocyte-to-monocyte ratio, and neutrophil-to-high-density-lipoprotein ratio are correlated with the severity of Parkinson's disease.
    Li F; Weng G; Zhou H; Zhang W; Deng B; Luo Y; Tao X; Deng M; Guo H; Zhu S; Wang Q
    Front Neurol; 2024; 15():1322228. PubMed ID: 38322584
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Unilateral GPi-DBS Improves Ipsilateral and Axial Motor Symptoms in Parkinson's Disease as Evidenced by a Brain Perfusion Single Photon Emission Computed Tomography Study.
    Hayashi Y; Mishima T; Fujioka S; Morishita T; Inoue T; Nagamachi S; Tsuboi Y
    Front Hum Neurosci; 2022; 16():888701. PubMed ID: 35634204
    [TBL] [Abstract][Full Text] [Related]  

  • 38. [Cognitive dysfuctions associated with essential tremor and Parkinson's disease].
    Chen J; Yao J; Wu Y; Chen Y; Mao C; Liu C
    Zhonghua Yi Xue Za Zhi; 2014 Aug; 94(31):2412-6. PubMed ID: 25400045
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Clinical Progression of Parkinson's Disease: Insights from the NINDS Common Data Elements.
    Lewis MM; Harkins E; Lee EY; Stetter C; Snyder B; Corson T; Du G; Kong L; Huang X
    J Parkinsons Dis; 2020; 10(3):1075-1085. PubMed ID: 32538866
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Quantitative mobility measures complement the MDS-UPDRS for characterization of Parkinson's disease heterogeneity.
    Hill EJ; Mangleburg CG; Alfradique-Dunham I; Ripperger B; Stillwell A; Saade H; Rao S; Fagbongbe O; von Coelln R; Tarakad A; Hunter C; Dawe RJ; Jankovic J; Shulman LM; Buchman AS; Shulman JM
    Parkinsonism Relat Disord; 2021 Mar; 84():105-111. PubMed ID: 33607526
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 10.